Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_assertion type Assertion NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_head.
- NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_assertion wasGeneratedBy ECO_0000203 NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_provenance.
- NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_assertion wasDerivedFrom befree-20140225 NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_provenance.
- NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_assertion SIO_000772 9120722 NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_provenance.
- NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_assertion evidence source_evidence_literature NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_provenance.
- NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_assertion description "[However, since P16 mutations were found only in metastatic tumours, they may be important events in late phases of tumour progression and could represent useful markers of tumour aggressiveness in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617213.RAXmCAx1eLYooGwrtLh_XcuifOkS_YMPe5nykuRo2e1IU130_provenance.